This raises the possibility that DMBT1 could antagonize surfactant supplementation in respiratory distress syndrome and could represent a candidate target molecule for therapeutic intervention in neonatal lung disease. This evidence concerns the gene DMBT1 and newborn respiratory distress syndrome.